US Stock MarketDetailed Quotes

CVKD Cadrenal Therapeutics

Watchlist
  • 0.431
  • +0.007+1.63%
Close Apr 26 16:00 ET
6.89MMarket Cap-670P/E (TTM)

Cadrenal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cadrenal Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.05

0.00%
Analyst Rating

Buy

Mar 31, 2024

Cadrenal Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--

Cadrenal Therapeutics Earnings Reports

  • Cadrenal Therapeutics | 10-K: Annual report

    Mar 12 00:58

  • Cadrenal Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 21:00

  • Cadrenal Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 18:06

  • Cadrenal Therapeutics | 10-Q: Quarterly report

    May 10, 2023 21:05

    • Read more

    Analysis

    Analyst Rating

    Updated: Mar 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg